XBiotech Inc. Quarterly Debt-to-equity in % from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
XBiotech Inc. quarterly Debt-to-equity history and growth rate from Q3 2015 to Q2 2024.
  • XBiotech Inc. Debt-to-equity for the quarter ending June 30, 2024 was 6.15 %, a 154% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 6.15 +3.73 +154% Jun 30, 2024
Q1 2024 4.47 +1.65 +58.4% Mar 31, 2024
Q4 2023 2.86 +0.12 +4.37% Dec 31, 2023
Q3 2023 2.58 -0.1 -3.74% Sep 30, 2023
Q2 2023 2.42 -0.12 -4.72% Jun 30, 2023
Q1 2023 2.82 +0.94 +49.9% Mar 31, 2023
Q4 2022 2.75 +1.11 +67.7% Dec 31, 2022
Q3 2022 2.68 +1.19 +79.9% Sep 30, 2022
Q2 2022 2.54 +0.99 +64% Jun 30, 2022
Q1 2022 1.88 -0.38 -16.8% Mar 31, 2022
Q4 2021 1.64 -1.16 -41.4% Dec 31, 2021
Q3 2021 1.49 -3.81 -71.9% Sep 30, 2021
Q2 2021 1.55 -4.39 -73.9% Jun 30, 2021
Q1 2021 2.26 -3.97 -63.7% Mar 31, 2021
Q4 2020 2.8 -4.6 -62.2% Dec 31, 2020
Q3 2020 5.3 +0.46 +9.51% Sep 30, 2020
Q2 2020 5.94 +0.52 +9.59% Jun 30, 2020
Q1 2020 6.23 +0.08 +1.3% Mar 31, 2020
Q4 2019 7.4 +2.06 +38.6% Dec 31, 2019
Q3 2019 4.84 +0.03 +0.62% Sep 30, 2019
Q2 2019 5.42 +0.51 +10.4% Jun 30, 2019
Q1 2019 6.14 +0.9 +17.2% Mar 31, 2019
Q4 2018 5.34 -0.45 -7.78% Dec 31, 2018
Q3 2018 4.81 -2.84 -37.1% Sep 30, 2018
Q2 2018 4.91 -3.72 -43.1% Jun 30, 2018
Q1 2018 5.24 -5.03 -49% Mar 31, 2018
Q4 2017 5.79 -4.48 -43.7% Dec 31, 2017
Q3 2017 7.65 -0.86 -10.1% Sep 30, 2017
Q2 2017 8.63 +1.46 +20.4% Jun 30, 2017
Q1 2017 10.3 +5.52 +116% Mar 31, 2017
Q4 2016 10.3 +5.72 +126% Dec 31, 2016
Q3 2016 8.5 +4.29 +102% Sep 30, 2016
Q2 2016 7.16 Jun 30, 2016
Q1 2016 4.76 Mar 31, 2016
Q4 2015 4.54 Dec 31, 2015
Q3 2015 4.21 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.